Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA
Authors:
- Isidro Cortes-CirianoICIsidro Cortes-Ciriano
- Christopher D. SteeleCSChristopher D. Steele
- Katherine PiculellKPKatherine Piculell
- Alyaa Al-IbraheemiAAAlyaa Al-Ibraheemi
- Vanessa EuloVEVanessa Eulo
- Marilyn M. BuiMBMarilyn M. Bui
- Aikaterini ChatzipliACAikaterini Chatzipli
- Brendan C. DicksonBDBrendan C. Dickson
- Dana C. BorcherdingDBDana C. Borcherding
- Andrew FeberAFAndrew Feber
- Alon GalorAGAlon Galor
- Jesse HartJHJesse Hart
Top Cited Papers
Open Access
- 4 January 2023
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Discovery
- Vol. 13  (3) , 654-671
Abstract
Malignant peripheral nerve sheath tumor (MPNST), an aggressive soft-tissue sarcoma, occurs in people with neurofibromatosis type 1 (NF1) and sporadically. Whole-genome and multiregional exome sequencing, transcriptomic, and methylation profiling of 95 tumor samples revealed the order of genomic events in tumor evolution. Following biallelic inactivation of NF1, loss of CDKN2A or TP53 with or without inactivation of polycomb repressive complex 2 (PRC2) leads to extensive somatic copy-number aberrations (SCNA). Distinct pathways of tumor evolution are associated with inactivation of PRC2 genes and H3K27 trimethylation (H3K27me3) status. Tumors with H3K27me3 loss evolve through extensive chromosomal losses followed by whole-genome doubling and chromosome 8 amplification, and show lower levels of immune cell infiltration. Retention of H3K27me3 leads to extensive genomic instability, but an immune cell-rich phenotype. Specific SCNAs detected in both tumor samples and cell-free DNA (cfDNA) act as a surrogate for H3K27me3 loss and immune infiltration, and predict prognosis. Significance: MPNST is the most common cause of death and morbidity for individuals with NF1, a relatively common tumor predisposition syndrome. Our results suggest that somatic copy-number and methylation profiling of tumor or cfDNA could serve as a biomarker for early diagnosis and to stratify patients into prognostic and treatment-related subgroups. This article is highlighted in the In This Issue feature, p. 517Keywords
All Related Versions
Funding Information
- Boston Children's Hospital (n/a)
This publication has 92 references indexed in Scilit:
- Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1Neuro-Oncology, 2012
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- DELLY: structural variant discovery by integrated paired-end and split-read analysisBioinformatics, 2012
- phangorn: phylogenetic analysis in RBioinformatics, 2010
- Allele-specific copy number analysis of tumorsProceedings of the National Academy of Sciences, 2010
- ANNOVAR: functional annotation of genetic variants from high-throughput sequencing dataNucleic Acids Research, 2010
- Image cytometry accurately detects DNA ploidy abnormalities and predicts late relapse to high-grade dysplasia and adenocarcinoma in Barrett's oesophagus following photodynamic therapyBritish Journal of Cancer, 2010
- ConsensusClusterPlus: a class discovery tool with confidence assessments and item trackingBioinformatics, 2010
- Fast and accurate long-read alignment with Burrows–Wheeler transformBioinformatics, 2010